June 2020 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
- How One Professor Built Two Billion-Dollar Biotechs
- A Chat On Biosimilars With Sandoz’s U.S. President Carol Lynch
Capitol Perspectives
CEO Corner
Companies To Watch
From Policy to Execution
Patient Perspective
Industry Research
Inside The Industry
- 7 Lessons In Supply Chain Management Learned From COVID-19
- A Future-Back Approach To Transformative Therapies
- Insights Into The Competitive Clinical Manufacturing Market
- Women Shaping The Life Sciences Industry In Tampa
- A Biopharma Dealmaker’s Approach To Maximizing Strategic Partnerships
Industry Leader
Leadership Lessons
Ask The Board
- How Can The Industry Effectively Partner With Health Agencies To Revamp Clinical Trials, Which Are A Major Factor For Slow/Costly Drug R&D?
- The Emerging CAR-T Therapies Are Brilliant But Appear Challenging When Trying To Reach A Large Population Of Patients. What Is The Prognosis Of Alternatives Such As Allogenic CAR-T Becoming Mainstream?
- In The Context Of Rising Clinical Trial Expenses, As A Result Of Increased Patient Numbers And Extended Time Frames, What Clinical Development Design Innovations Will We Observe In The Next Two To Five Years?
This website uses cookies to ensure you get the best experience on our website. Learn more